Lupin to present Phase 1a clinical trial data of STING agonist LNP3693 at ESMO Congress 2025 EP News Bureau Oct 13, 2025 Lupin to share findings on LNP3693’s safety, pharmacokinetics, and anti-tumour activity in advanced solid tumours and lymphoma at…
